Word

X-PATH

Status

Registered

Status Code

700

Status Date

Tuesday, October 18, 2022

Serial Number

88333627

Registration Number

6880311

Registration Date

Tuesday, October 18, 2022

Mark Type

4000

Filing Date

Monday, March 11, 2019

Published for Opposition

Tuesday, December 10, 2019

Trademark Owner History

Essenlix Corporation - Original Registrant

Classifications

5 Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes; Biological and chemical test kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids and substances extracted from bodily fluids, namely, cells, proteins, small molecules, nucleotides, and nucleic acids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases

1 Assays for research purposes; Biological and chemical reagents used for non-medical research and laboratory purposes, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits comprised of biological, chemical, or diagnostic reagents for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, for laboratory and research use

44 Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services, namely, the diagnosis of diseases, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information in the fields of health and wellness; Medical services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes

10 Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, in the nature of apparatus for DNA and RNA testing for medical purposes

42 Scientific laboratory services, namely, detection and identification of cells, proteins, small molecules, and nucleotides in a sample for scientific, research, and technological purposes; Medical laboratory services, namely, providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of infectious and residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; Development of new technology for others in the fields of biotechnology, DNA, RNA, small molecules, proteins, and nucleotide analysis services for scientific research purposes; Providing medical and scientific research information in the field of clinical trials, assays and assay development, diagnostics, cancer, RNA, DNA, small molecules, proteins, and nucleotides; Research and development in the medical and digital diagnostics and biotechnology fields; Custom design and development of chemical reagents and biochemical assays; Laboratory research in the field of oncology, hematology, and infectious diseases

Trademark Events

Oct 18, 2022

Notice Of Registration Confirmation Emailed

Oct 18, 2022

Registered-Principal Register

Sep 14, 2022

Notice Of Acceptance Of Statement Of Use E-Mailed

Sep 13, 2022

Allowed Principal Register - Sou Accepted

Aug 9, 2022

Statement Of Use Processing Complete

Aug 4, 2022

Use Amendment Filed

Aug 4, 2022

Teas Statement Of Use Received

Feb 5, 2022

Notice Of Approval Of Extension Request E-Mailed

Feb 3, 2022

Sou Extension 4 Granted

Feb 3, 2022

Sou Extension 4 Filed

Feb 3, 2022

Teas Extension Received

Aug 10, 2021

Notice Of Approval Of Extension Request E-Mailed

Aug 9, 2021

Sou Extension 3 Granted

Aug 4, 2021

Sou Extension 3 Filed

Aug 4, 2021

Teas Extension Received

Jan 27, 2021

Notice Of Approval Of Extension Request E-Mailed

Jan 25, 2021

Sou Extension 2 Granted

Jan 25, 2021

Sou Extension 2 Filed

Jan 25, 2021

Teas Extension Received

Nov 13, 2020

Notice Of Approval Of Extension Request E-Mailed

Nov 12, 2020

Sou Extension 1 Granted

Aug 4, 2020

Sou Extension 1 Filed

Nov 9, 2020

Case Assigned To Intent To Use Paralegal

Sep 29, 2020

Notice Of Revival - E-Mailed

Sep 29, 2020

Extension Received With Teas Petition

Sep 29, 2020

Petition To Revive-Granted

Sep 29, 2020

Teas Petition To Revive Received

Sep 8, 2020

Abandonment Notice E-Mailed - No Use Statement Filed

Sep 7, 2020

Abandonment - No Use Statement Filed

Feb 4, 2020

Noa E-Mailed - Sou Required From Applicant

Dec 10, 2019

Official Gazette Publication Confirmation E-Mailed

Dec 10, 2019

Published For Opposition

Nov 20, 2019

Notification Of Notice Of Publication E-Mailed

Nov 7, 2019

Assigned To Lie

Nov 4, 2019

Approved For Pub - Principal Register

Nov 4, 2019

Examiner's Amendment Entered

Nov 4, 2019

Notification Of Examiners Amendment E-Mailed

Nov 4, 2019

Examiners Amendment E-Mailed

Nov 4, 2019

Examiners Amendment -Written

May 8, 2019

Notification Of Non-Final Action E-Mailed

May 8, 2019

Non-Final Action E-Mailed

May 8, 2019

Non-Final Action Written

May 6, 2019

Assigned To Examiner

Mar 28, 2019

New Application Office Supplied Data Entered In Tram

Mar 14, 2019

New Application Entered In Tram